Neoadjuvant therapy in melanoma with Georgina Long | 45 min
In this interview from Oncology News Australia, MIA’s Prof Georgina Long AO speaks with Prof Hans Prenen on a recent publication in Nature Medicine on pathological response and survival with neoadjuvant therapy in melanoma.
This interview is from The Oncology Journal Club podcast series and the link will take you to the Oncology News Australia website.
Please note that this podcast was accurate at the time of recording (February 2021) but may not reflect the rapidly evolving treatment landscape and approvals in Australia.
Professor Georgina Long AO
Co-Medical Director, Melanoma Institute Australia
Chair, Melanoma Medical Oncology and Translational Research, Melanoma Institute Australia and Royal North Shore Hospital, The University of Sydney
Declaration of Interest
Professor Hans Prenen
Medical Oncologist and Deputy Head of the Oncology Department at University Hospital Antwerp